Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Advanced Enzyme Technologies's Days Inventory or its related term are showing as below:
NSE:ADVENZYMES'
s Days Inventory Range Over the Past 10 Years
Min: 295.02 Med: 312.49 Max: 341.82
Current: 320.32
During the past 13 years, Advanced Enzyme Technologies's highest Days Inventory was 341.82. The lowest was 295.02. And the median was 312.49.
NSE:ADVENZYMES's Days Inventory is ranked worse than 96.11% of 1541
companies
in the Chemicals industry
Industry Median: 80.49
vs NSE:ADVENZYMES: 320.32
Inventory Turnover measures how fast the company turns over its inventory within a year.
Advanced Enzyme Technologies's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.32.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Advanced Enzyme Technologies's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.87.
Advanced Enzyme Technologies (NSE:ADVENZYMES) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Advanced Enzyme Technologies's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Advanced Enzyme Technologies's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Advanced Enzyme Technologies Days Inventory Related Terms
Advanced Enzyme Technologies Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:ADVENZYMES vs LIN, SHW, ECL: Days Inventory Comparison
For the Specialty Chemicals subindustry, Advanced Enzyme Technologies's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Advanced Enzyme Technologies Days Inventory vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Advanced Enzyme Technologies's Days Inventory distribution charts can be found below:
* The bar in red indicates where Advanced Enzyme Technologies's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Advanced Enzyme Technologies (NSE:ADVENZYMES) has a Days Inventory of 284.15 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Advanced Enzyme Technologies and its competitors. This is near median its historical median of 312.49. Over the past decade, Advanced Enzyme Technologies' Days Inventory has ranged from 295.02 to 341.82. According to the industry distribution chart, Advanced Enzyme Technologies ranks #1481 out of 1541 companies in the Chemicals industry, placing it in the top 96.1%.
Is Advanced Enzyme Technologies' Days Inventory too high?
Advanced Enzyme Technologies' current Days Inventory of 284.15 is near median its 10-year median of 312.49. Over the past 10 years, this metric has ranged from a low of 295.02 to a high of 341.82. The Chemicals industry median Days Inventory is 80.49. Advanced Enzyme Technologies' value of 284.15 is 253% above this industry median. Based on the distribution chart, Advanced Enzyme Technologies ranks #1481 out of 1541 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Advanced Enzyme Technologies has a GF Score™ of 89/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Advanced Enzyme Technologies' Days Inventory compare to LIN and SHW?
According to the Chemicals industry distribution chart, Advanced Enzyme Technologies ranks #1481 out of 1541 companies for Days Inventory. This places Advanced Enzyme Technologies in the lower half of its industry. The industry median Days Inventory is 80.49. Advanced Enzyme Technologies' value of 284.15 is 253% above this benchmark. Historically, Advanced Enzyme Technologies' own Days Inventory has ranged from 295.02 to 341.82 over the past decade. While the company's 10-year median is 312.49 vs. the industry median of 80.49, Advanced Enzyme Technologies has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Chemicals company?
The median Days Inventory among Chemicals companies is 80.49, based on 1,541 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Advanced Enzyme Technologies's current Days Inventory of 284.15 is 253% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Advanced Enzyme Technologies and its competitors. For the Chemicals industry, the median Days Inventory is 80.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Advanced Enzyme Technologies's current Days Inventory is 284.15, which is near median its own 10-year median of 312.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Advanced Enzyme Technologies stock overvalued right now?
Based on GuruFocus' analysis, Advanced Enzyme Technologies (NSE:ADVENZYMES) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹420.89, compared to a current price of ₹324.35 — trading 22.9% below its estimated fair value. The current Days Inventory is 284.15, which is near median its 10-year median of 312.49 and 253% above the Chemicals industry median of 80.49. Advanced Enzyme Technologies' overall GF Score™ is 89/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Advanced Enzyme Technologies (NSE:ADVENZYMES), the current Days Inventory is 284.15 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Advanced Enzyme Technologies (NSE:ADVENZYMES) Overvalued in 2026?
Based on GuruFocus' analysis, Advanced Enzyme Technologies stock appears to be undervalued.
The current stock price of ₹324.35 is trading 22.9% below its estimated GF Value™ of ₹420.89.
GuruFocus considers Advanced Enzyme Technologies to be Modestly Undervalued.
Key valuation signals for NSE:ADVENZYMES:
Days Inventory: 284.15 (near median its 10-year median of 312.49)
GF Value™: ₹420.89 vs. price of ₹324.35 (22.9% below fair value)
Industry Position: 253% above the Chemicals median (#1481 of 1541)
No single metric tells the full story. See the NSE:ADVENZYMES stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Advanced Enzyme Technologies Ltd is an Indian company engaged in research activities to manufacture and sell enzymes. The company operates only in one business segment, viz., manufacturing and sales of enzymes. The company offers enzymes for human healthcare and nutrition, animal nutrition, food processing, and non-food processing. Some of the products offered by the company are serratiopeptidase, fungal lipase, papain, hemicellulose, and digegrain, among others. Geographically, the entity operates in India, Europe, the USA, Asia, and other countries, of which a majority of the revenue is derived from India.
89GF Score
Get the complete analysis for NSE:ADVENZYMES
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ADVENZYMES has been successfully added to your 
